Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Disallow: https://courpharma.com/wp-content/uploads/wpforms/ # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://courpharma.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Homepage - COUR |
Description | Reprogramming the Immune COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific |
Keywords | N/A |
WebSite | courpharma.com |
Host IP | 34.230.198.252 |
Location | United States |
Site | Rank |
US$11,062,109
Last updated: 2023-05-09 06:31:58
courpharma.com has Semrush global rank of 956,807. courpharma.com has an estimated worth of US$ 11,062,109, based on its estimated Ads revenue. courpharma.com receives approximately 1,276,398 unique visitors each day. Its web server is located in United States, with IP address 34.230.198.252. According to SiteAdvisor, courpharma.com is safe to visit. |
Purchase/Sale Value | US$11,062,109 |
Daily Ads Revenue | US$10,212 |
Monthly Ads Revenue | US$306,336 |
Yearly Ads Revenue | US$3,676,024 |
Daily Unique Visitors | 85,094 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
courpharma.com. | A | 598 | IP: 34.230.198.252 |
courpharma.com. | NS | 3600 | NS Record: ns40.domaincontrol.com. |
courpharma.com. | NS | 3600 | NS Record: ns39.domaincontrol.com. |
courpharma.com. | MX | 3600 | MX Record: 0 courpharma-com.mail.protection.outlook.com. |
courpharma.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
courpharma.com. | TXT | 600 | TXT Record: MS=ms71654607 |
courpharma.com. | TXT | 600 | TXT Record: g45fqtrpm3md5fb92m5460ro3t |
courpharma.com. | TXT | 600 | TXT Record: google-site-verification=IPzpuhApndn5xg5C8kckl-zgT7KLqVb-bDCoc-gA70g |
The Latest COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director Skip to primary navigation Skip to footer COUR Pharmaceuticals Our Company Leadership Advisors Partners Contact Our Technology Pipeline Autoimmune Diseases Allergies Rare Diseases Gene Therapy Our Clinical Trials Publications & Media Press Releases Publications Careers Reprogramming the Immune System About COUR Who We Are COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. COUR’s platform of immune-modifying nanoparticles aims to treat the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression. COUR’s lead product for celiac disease, partnered with Takeda, is the first demonstration of induction of antigen-specific immune tolerance in any autoimmune disease. Data |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 31 Oct 2021 10:09:50 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive X-Powered-By: PHP/7.4.25 X-Redirect-By: WordPress Location: https://courpharma.com/ Cache-Control: max-age=0 Expires: Sun, 31 Oct 2021 10:09:49 GMT Vary: Accept-Encoding X-Powered-By: PleskLin HTTP/2 200 server: nginx date: Sun, 31 Oct 2021 10:09:50 GMT content-type: text/html; charset=UTF-8 x-powered-by: PHP/7.4.25 last-modified: Sun, 31 Oct 2021 01:52:25 GMT cache-control: max-age=0 expires: Sun, 31 Oct 2021 10:09:50 GMT vary: Accept-Encoding x-powered-by: PleskLin |
Domain Name: COURPHARMA.COM Registry Domain ID: 1764289467_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-12-06T18:44:21Z Creation Date: 2012-12-06T01:57:09Z Registry Expiry Date: 2021-12-06T01:57:09Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS39.DOMAINCONTROL.COM Name Server: NS40.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T20:03:05Z <<< |